Literature DB >> 17659920

Relation of moderate or severe reduction in glomerular filtration rate to number of coronary arteries narrowed >50% in patients undergoing coronary angiography for suspected coronary artery disease.

Omar Khalique1, Wilbert S Aronow, Chul Ahn, Michael Mazar, Barry Schair, John Shao, Venu Channamsetty.   

Abstract

We investigated, in a prospective study of 1,007 patients who underwent coronary angiography for suspected coronary artery disease (CAD), the association of obstructive CAD with severe or moderate decrease in glomerular filtration rate (GFR) calculated from the Modification of Diet in Renal Disease equation. Baseline characteristics were similar in patients with a moderate or severe GFR decrease (<60 ml/min/1.73 m(2)) and those with a mild or no GFR decrease except for diabetes being present in 112 of 259 patients (43%) with a moderate or severe GFR decrease and in 206 of 748 patients (28%) with a mild or no GFR decrease (p <0.001). Three-vessel CAD was present in 138 of 259 patients (53%) with a moderate or severe GFR decrease and in 170 of 748 patients (23%) with a mild or no GFR decrease (p <0.001). One- to 3-vessel CAD was present in 225 of 259 patients (87%) with a moderate or severe GFR decrease and in 533 of 748 patients (71%) with a mild or no decrease in GFR (p <0.001). Logistic regression analysis showed that patients with a moderate or severe GFR decrease had a 4.1 times higher risk of developing 3-vessel CAD after controlling for the effect of diabetes compared with patients with a mild or no GFR decrease (relative risk 4.1, 95% confidence interval 3.0 to 5.5). In conclusion, a moderate or severe decrease in GFR is a significant risk factor for 1- to 3-vessel obstructive CAD, especially 3-vessel obstructive CAD.

Entities:  

Mesh:

Year:  2007        PMID: 17659920     DOI: 10.1016/j.amjcard.2007.03.038

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

1.  Glomerular filtration rate is related to severity of obstructive coronary artery disease in patients undergoing coronary angiography.

Authors:  Gholamreza Davoodi; Samira Mehrabi Pari; Mehrnaz Rezvanfard; Mahmood Sheikh Fathollahi; Manouchehr Amini; Elham Hakki; Ali Kazemisaeid; Ahmad Yaminisharif
Journal:  Int Urol Nephrol       Date:  2011-10-16       Impact factor: 2.370

2.  Association of coronary artery disease and chronic kidney disease in Lebanese population.

Authors:  Aline Milane; Georges Khazen; Nabil Zeineddine; Mazen Amro; Leila Masri; Michella Ghassibe-Sabbagh; Sonia Youhanna; Angelique K Salloum; Marc Haber; Daniel E Platt; Jean-Baptiste Cazier; Raed Othman; Samer Kabbani; Hana Sbeite; Youssef Chami; Elie Chammas; Hamid El Bayeh; Dominique Gauguier; Antoine B Abchee; Pierre Zalloua; Antoine Barbari
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Trimethylamine N-Oxide and Cardiovascular Outcomes in Patients with ESKD Receiving Maintenance Hemodialysis.

Authors:  Jason R Stubbs; Margaret R Stedman; Sai Liu; Jin Long; Yoko Franchetti; Raymond E West; Alexander J Prokopienko; Jonathan D Mahnken; Glenn M Chertow; Thomas D Nolin
Journal:  Clin J Am Soc Nephrol       Date:  2019-01-21       Impact factor: 8.237

4.  Diverging association of reduced glomerular filtration rate and albuminuria with coronary and noncoronary events in patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.

Authors:  Anna Solini; Giuseppe Penno; Enzo Bonora; Cecilia Fondelli; Emanuela Orsi; Maura Arosio; Roberto Trevisan; Monica Vedovato; Mauro Cignarelli; Francesco Andreozzi; Antonio Nicolucci; Giuseppe Pugliese
Journal:  Diabetes Care       Date:  2011-11-28       Impact factor: 19.112

5.  Kidney Function Does Not Modify the Favorable Quality of Life Changes Associated With Revascularization for Coronary Artery Disease: Cohort Study.

Authors:  Matthew T James; Stephen B Wilton; Fiona M Clement; William A Ghali; Merril L Knudtson; Zhi Tan; Marcello Tonelli; Brenda R Hemmelgarn; Colleen M Norris
Journal:  J Am Heart Assoc       Date:  2016-07-19       Impact factor: 5.501

6.  Clinical Significance of Cys-C and hs-CRP in Coronary Heart Disease Patients Undergoing Percutaneous Coronary Intervention.

Authors:  Zheng Tan; Li Li; Yi Ma; Xuebin Geng
Journal:  Braz J Cardiovasc Surg       Date:  2019 Jan-Feb

7.  Influenza vaccination reduces incidence of peripheral arterial occlusive disease in elderly patients with chronic kidney disease.

Authors:  Ping-Jen Hu; Chia-Hsien Chen; Chung-Shun Wong; Tzu-Ting Chen; Mei-Yi Wu; Li-Chin Sung
Journal:  Sci Rep       Date:  2021-03-01       Impact factor: 4.379

8.  Randomized, Placebo-Controlled Trial of Rifaximin Therapy for Lowering Gut-Derived Cardiovascular Toxins and Inflammation in CKD.

Authors:  Cassandra Kimber; Shiqin Zhang; Cassandra Johnson; Raymond E West; Alexander J Prokopienko; Jonathan D Mahnken; Alan S Yu; Andrew N Hoofnagle; Diana Ir; Charles E Robertson; Makoto Miyazaki; Michel Chonchol; Anna Jovanovich; Bryan Kestenbaum; Daniel N Frank; Thomas D Nolin; Jason R Stubbs
Journal:  Kidney360       Date:  2020-11-25

9.  Decreased renal function is an independent predictor of severity of coronary artery disease: an application of Gensini score.

Authors:  Il Young Kim; In Hye Hwang; Kyung Nam Lee; Dong Won Lee; Soo Bong Lee; Min Ji Shin; Harin Rhee; Byeongyun Yang; Sang Heon Song; Eun Young Seong; Ihm Soo Kwak
Journal:  J Korean Med Sci       Date:  2013-10-31       Impact factor: 2.153

10.  The risk of atherosclerosis in patients with chronic kidney disease.

Authors:  Sylwia Olechnowicz-Tietz; Anna Gluba; Anna Paradowska; Maciej Banach; Jacek Rysz
Journal:  Int Urol Nephrol       Date:  2013-03-13       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.